NCT06173973
Effects of Ketone Supplementation on Acute Alcohol Withdrawal
Enrolling by Invitation
PHASE2Ages 18–75InterventionalBasic scienceUniversity of PennsylvaniaInvestigator-initiated
~50 participants
Updated 2026-04-06 on ClinicalTrials.gov
What's tested:Kenetik; Ketone ConcentrateIsocaloric dextrose placebo
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Effects of ketone supplement Kenetik, three times daily (TID), versus placebo, on the need for benzodiazepines (daily use in mg).
Measured over 5 days
Conditions
Where it's being run
2 sites across 1 statesPennsylvania2
Study leadership
- Corinde E Wiers, Ph.D. · PRINCIPAL_INVESTIGATOR · University of Pennsylvania
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Effects of ketone supplement Kenetik, three times daily (TID), versus placebo, on the need for benzodiazepines (daily use in mg).5 days
To examine the effects of ketone supplement Kenetik, three times daily (TID), versus placebo, on the need for benzodiazepines (daily use in mg), while undergoing inpatient acute withdrawal management.